NY-AQARA
Aqara, a leading provider of smart home products, announces the wide availability of the Company’s first smart video doorbell, the G4, on global markets. This 1080p doorbell features wide compatibility with third-party smart home platforms such as Apple Home, Alexa and Google Home, and it is equipped with on-device AI to enable local facial recognition alerts and automation. Together with the Company’s indoor cameras, the video doorbell G4 helps users keep an eye on their homes, families and visitors anytime, anywhere. The device is now available on Aqara’s Amazon brand stores in both North America (US, Canada) and Europe (France, Germany, Italy, Spain, UK) as well as via selective Aqara retailers worldwide1.
Similar to Aqara’s Camera Hub G3, the Aqara Smart Video Doorbell G4 features AI-based facial recognition, which is executed locally on device for faster response and privacy protection. Moreover, facial recognition of the doorbell can be used as an automation trigger, allowing users to set up customized home automation for different families and visitors. For example, the welcome home scene will be activated when the G4 recognizes a family member coming home. Or in the case that it detects the postman, the doorbell will play a pre-recorded message. When connected to other Aqara devices, the G4 doorbell can also be a strong addition to the Aqara Home alert system as it not only monitors the activities around the front porch but also lets out a loud siren in case of home intrusion and other emergencies.
Apart from the Aqara ecosystem, the G4 doorbell also supports major third-party smart home platforms including Apple Home, Amazon Alexa and Google Home. This device is one of the few battery-powered video doorbells on the market that support Apple’s HomeKit Secure Video as well as the local streaming to Amazon and Google smart displays. Moreover, Aqara anticipates adding the support of the new Matter standard to the G4 via a future OTA (over the air) update2.
With two color variants, Shadow Gray and Black, the video doorbell G4 is designed to fit into most home environments. It supports both wireless and wired installation and can use a pack of 6 AA batteries that lasts about 4 months3. The doorbell offers adjustable sensitivity, configurable motion detection and even a power saving mode for users who live in a high traffic area to extend the battery life. Alternatively, users can opt to wire the G4 doorbell to an AC/DC transformer for 24/7 recording4, and use the battery pack as a back-up power source. Additionally, the G4’s chime repeater, which is equipped with a 95 dB speaker, houses a Type-C port, and allows more flexibility for users to place the chime repeater indoors.
Users of the Video Doorbell G4 can store video footage locally or on the cloud via iCloud or Aqara platform5. Aqara offers a subscription-free cloud storage of up to 7 days of critical event clips such as motion detection, facial recognition, doorbell ring and tamper alerts. Users can also choose to save video footage locally using a microSD card (up to 512 GB)6, which is housed in the indoor chime repeater. Finally, videos can also be stored via SMB NAS for added flexibility and security7.
For more details of the G4 video doorbell, please visit our website.
- Product availability may vary among different retail channels, and could be updated all the time. It’s recommended to check with the regional retailer(s) for real time availability.
- Matter support is not available by the time of launch.
- Based on assumption of 35 device wake-ups and one 6-second event video recording per day. The actual battery life may vary, depending on multiple factors including device usage, battery capacity, ambient temperature, etc.
- A 12-24V AC or 8-24V DC transformer is required. Both a wired installation and the use of a microSD card are required for 24/7 recording.
- iCloud or other supported cloud storage is not included, and should be controlled separately via the respecting app.
- The microSD card is not included.
- SMB NAS support may be unavailable by the time of product launch.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005016/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom